Physician profile
Ellen Kingdom
NPI 1508480542
$3,423.86
in general payments reported to CMS, 2019-2025
30 companies · $453 in 2025
The $453 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $414 · 2022: $501 · 2023: $1,339 · 2024: $717 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,345 · Education: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,344.69 |
| Education | $164.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $568.00 | 2021-2024 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $421.56 | 2022-2025 | Erleada |
| Sumitomo Pharma America, INC. | $370.62 | 2023-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $320.70 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $218.17 | 2021-2025 | |
| Accord Healthcare, INC. | $146.61 | 2023-2025 | |
| Abbvie INC. | $142.46 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $136.01 | 2023-2025 | Keytruda, Lynparza, Welireg |
| Sunovion Pharmaceuticals INC. | $129.15 | 2021-2022 | |
| 180 Medical, INC. | $115.32 | 2021-2024 | |
| Blue Earth Diagnostics | $96.40 | 2023 | |
| C. R. Bard, INC. & Subsidiaries | $83.38 | 2023-2025 | Bard Urinary Drainage Bag |
| Teleflex LLC | $71.59 | 2023-2025 | Urolift |
| Boston Scientific Corporation | $67.33 | 2024-2025 | Spaceoar Vue System - 10ml |
| Novartis Pharmaceuticals Corporation | $63.67 | 2023 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $62.76 | 2021-2023 | |
| Myovant Sciences INC. | $53.47 | 2021-2022 | |
| Amgen INC. | $48.56 | 2023 | Xgeva |
| Dendreon Pharmaceuticals LLC | $45.62 | 2022-2024 | Provenge |
| Progenics Pharmaceuticals, INC. | $34.20 | 2023-2024 | Pylarify |
| Allergan, INC. | $34.17 | 2021 | |
| Endo Pharmaceuticals INC. | $31.73 | 2021-2023 | Xiaflex, Aveed |
| Tempus Ai, INC | $30.10 | 2025 | Xt Cdx |
| Angiodynamics, INC. | $26.91 | 2024 | Nanoknife |
| Rochester Medical Corporation | $23.65 | 2022 | |
| Myriad Genetic Laboratories, INC. | $22.48 | 2022 | |
| Coloplast Corp | $17.75 | 2022 | |
| Dentsply Ih Ab | $17.13 | 2021 | |
| Photocure INC | $14.40 | 2022 | |
| Travere Therapeutics, INC. | $9.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Kingdom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.